Document is current

Article History

Received: 26 September 2022

Accepted: 6 March 2023

First Online: 20 March 2023

Declarations

:

: The study procedures were carried out in accordance with the Declaration of Helsinki. This study was approved by the Sun Yat-sen University, School of Public Health Institutional Review Board (Ethics Number: L2017060). Before the study commenced, the students and their parents were informed of the purpose of the study, that participation was voluntary, and that their answers were anonymous and confidential. Written informed consent was obtained from all participating students as well as one of their parents.

: Not applicable.

: RS.M has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC); speaker/consultation fees from Lundbeck, Janssen, Alkermes, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Abbvie, Atai Life Sciences. Roger S. McIntyre is the CEO of Braxia Scientific Corp. KM.T has received personal fees from Braxia Scientific Corp. Rest all other authors have no competing interests to declare. The funding organizations had no role in design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.